fda covid shots - Search News

Order byBest matchMost fresh

FDA, Covid and fall vaccines

FDA picks a new strain for fall Covid vaccines. Here's what it means for your next shot.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most at-risk Americans this fall.

· 2h · on MSN

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

STAT · 1h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

· 23h

FDA panel recommends keeping COVID shots targeted to same strain as last year

Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...

wtvr · 21h

FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals

· 1d

FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules

· 1d

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

· 22h

COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say

The F.D.A. May Restrict Covid Shots. Who Will Be Able to Get Them?

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all Americans over 6 months of age.

19hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

2don MSN

Moderna Pulls Application for Flu-Covid Combo Shot in Setback

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu shot for people 50 and over, a setback for the company.

1don MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.